FDA Grants Breakthrough Device Designation to MeMed Severity Test for Patients with Suspected Sepsis
-Major Development Milestone Reinforces MeMed’s Leadership in Host-Response Diagnostics- -FDA Endorsement Accelerates Product Development and Market Readiness- ANDOVER, Mass. & HAIFA, Israel–(BUSINESS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results